Form 4: Mainz Biomed CFO Receives Stock Grant
Insider Transaction (Form 4)
William J Caragol, Chief Financial Officer of Mainz Biomed N.V., received 212,500 shares of common stock on July 31, 2026.
Summary
- Grant/award: acquired 212,500 Stock Option (Right to Buy) on July 31, 2026; holds 212,500 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
William J Caragol — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Stock Option (Right to Buy) | 212,500 | — | — | 212,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (212,500 shares) |
Keywords
insider transaction, Form 4, QUCY, Quantum Cyber N.V., neutral, William J Caragol
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.